Work

Dupilumab efficacy and safety in patients with moderate-to-severe COPD with type 2 inflammation: pooled analysis of BOREAS and NOTUS

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.pa4787

Authors: Surya Bhatt, Klaus F. Rabe, Nicola Hanania, Claus F Vogelmeier, Mona Bafadhel, Stephanie Christenson, Alberto Papi, Dave Singh, Elizabeth Laws, Bolanle Akinlade, Jennifer Maloney, Xin Lu, Deborah Bauer, Ashish Bansal, Raolat M Abdulai, Lacey B Robinson, Surya Bhatt

Institutions: University of Alabama at Birmingham, German Center for Lung Research, LungenClinic Grosshansdorf, Baylor College of Medicine, Philipps University of Marburg, King's College London, University of California, San Francisco, University of Ferrara, University of Manchester, Manchester University NHS Foundation Trust, Sanofi (United States), Regeneron (United States)

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404096813

Cites:

Cited by:

Related to: 10